# KC-WISE (NCT05427383)

> KN026 in Combination With Chemotherapy in HER2 Positive Gastric Cancer Subjects Who Have Failed First-line Therapy

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05427383
- Phase: PHASE2, PHASE3
- Status: RECRUITING
- Sponsor: Shanghai JMT-Bio Inc.
- Conditions: Stomach Cancer
- Interventions: KN026/Placbo Injection; Paclitaxel Injection; Docetaxel Injection; Irinotecan Injection
- Enrollment: 286
- Primary outcome: Progression Free Survival (PFS) according to RECIST 1.1 by IRC
- Primary outcome: Overall Survival (OS) according to RECIST 1.1 by IRC

## Indexed commentary on KC-WISE so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 16

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=kc-wise-nct05427383

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT05427383", "email": "<work email>"}; the inbox owner confirms by the emailed link.